| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070207967 Peptide Inhibitors of Matrix Metalloproteinase Activity |
| 09/06/2007 | US20070207486 determining whether a patient will respond to anti-VEGF antibody based chemotherapy by screening suitable cell or tissue sample from the patient for at least one genomic polymorphism or genotype; using a bevacizumab antibody or an antibody that binds to the same epitope on VEGF and and cyclophosphamide |
| 09/06/2007 | US20070207210 Protein Microspheres Retaining Pharmacokinetic and Pharmacodynamic Properties |
| 09/06/2007 | US20070207187 Functional Composition Or Food Comprising Whey Protein, Antibody Derived From Milk Or Antibody |
| 09/06/2007 | US20070207171 Engineered listeria and methods of use thereof |
| 09/06/2007 | US20070207170 Engineered Listeria and methods of use thereof |
| 09/06/2007 | US20070207169 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children |
| 09/06/2007 | US20070207168 Use of vaccines for the treatment/prevention of the transmission of pathogens |
| 09/06/2007 | US20070207167 Immunologically enhanced recombinant vaccines |
| 09/06/2007 | US20070207166 Method of Using Adenoviral Vectors to Induce an Immune Response |
| 09/06/2007 | US20070207165 An isolated recombinant Piscirickettsia salmonis (SRS) 45 Kda (Psp45) polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or NO: 4; fish diseases, particularly farmed salmon;immunogens; recombinant Yersinia ruckeri cells to be used to construct vaccines for SRS as well as other pathogens |
| 09/06/2007 | US20070207164 Methods of using flt3-ligand in the treatment of cancer |
| 09/06/2007 | US20070207163 Recombinant soluble Fc receptors |
| 09/06/2007 | US20070207162 Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system |
| 09/06/2007 | US20070207161 Immunomodulating Compositions and uses Therefor |
| 09/06/2007 | US20070207160 Apoptosis inhibitors |
| 09/06/2007 | US20070207159 Compositions and methods for enhancing antigen-specific immune response |
| 09/06/2007 | US20070207158 Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof |
| 09/06/2007 | US20070207157 Adjuvant Theraphy of G250-Expressing Tumors |
| 09/06/2007 | US20070207156 Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules |
| 09/06/2007 | US20070207155 Producing antibodies against platelet membrane glycoprotein VI (GPVI); for detection and treatment of thrombosis and other vascular diseases |
| 09/06/2007 | US20070207154 Method of modulating vascularization |
| 09/06/2007 | US20070207153 Therapeutic Agents For Inner Ear Disorders Containing An Il-6 Antagonist As An Active Ingredient |
| 09/06/2007 | US20070207152 Monoclonal antibody specific for brain natriuretic peptide for use in diagnosis, prevention and treatment of cardiovascular disorders |
| 09/06/2007 | US20070207151 Method of Modulating the Activity of Functional Immune Molecules |
| 09/06/2007 | US20070207150 Annexin V is used to prevent thrombosis without increasing hemorrhage; annexin binds to phosphatidylserine on outer surface of cell membranes, thereby preventing binding of prothrombinase complex necessary for thrombus formation |
| 09/06/2007 | US20070207149 Cancer treatment using viruses and camptothecins |
| 09/06/2007 | US20070207148 Genes associated with obesity and methods for using the same |
| 09/06/2007 | US20070207147 Nucleotide sequences coding membrane protein ; antiproliferative agents; anticancer agents; antiinflammatory agents |
| 09/06/2007 | US20070207146 Therapeutic using a bispecific antibody |
| 09/06/2007 | US20070207145 Mouse/human chimeric anti-phencyclidine antibody and uses thereof |
| 09/06/2007 | US20070207144 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy |
| 09/06/2007 | US20070207143 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 09/06/2007 | US20070207142 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 09/06/2007 | US20070207141 Methods of treating inflammatory and autoimmune diseases with natalizumab |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | US20070207129 Compositions and methods for inducing chimerism in a subject |
| 09/06/2007 | US20070207121 Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration |
| 09/06/2007 | US20070207120 Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6 |
| 09/06/2007 | US20070207090 Mucosal meningococcal vaccines |
| 09/05/2007 | EP1830187A1 Methods of and compositions for modulating hair growth via p-cadherin modulators |
| 09/05/2007 | EP1829962A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829961A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829895A1 Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| 09/05/2007 | EP1829892A2 Staphylococcus aureus proteins and nucleic acids |
| 09/05/2007 | EP1829887A1 Cpg single-strand deoxynucleotides for use as adjuvant |
| 09/05/2007 | EP1829552A2 Chlamydia PMP proteins, gene sequences and uses thereof |
| 09/05/2007 | EP1829551A1 Modified heat shock protein-antigenic peptide complex |
| 09/05/2007 | EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome |
| 09/05/2007 | EP1828378A2 Deacylation of lps in gram negative bacteria |
| 09/05/2007 | EP1828251A2 Methods and compositions for improving recombinant protein production |
| 09/05/2007 | EP1828249A2 Biomarkers for pre-selection of patients for anti-igf1r therapy |
| 09/05/2007 | EP1828248A2 Compositions comprising anti-igf-1 receptor antibodies and methods for obtaining said antibodies |
| 09/05/2007 | EP1828247A2 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 09/05/2007 | EP1827604A1 Methods and compositions for adoptive immunotherapy |
| 09/05/2007 | EP1827603A2 Novel pharmaceutical composition containing at least one dolastatin 10 derivative |
| 09/05/2007 | EP1827504A2 Recombinant bcg strains with enhanced ability to escape the endosome |
| 09/05/2007 | EP1827493A2 Use of anti-abeta antibody to treat traumatic brain injury |
| 09/05/2007 | EP1827492A2 Antibodies directed to gpnmb and uses thereof |
| 09/05/2007 | EP1827491A2 Treatment for multiple sclerosis |
| 09/05/2007 | EP1827490A2 Implantable device |
| 09/05/2007 | EP1827489A2 Use of flagellin in tumor immunotherapy |
| 09/05/2007 | EP1827488A1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 09/05/2007 | EP1827487A2 Cancer immunotherapy incorporating p53 |
| 09/05/2007 | EP1827437A2 Combinations of therapeutic agents for treating cancer |
| 09/05/2007 | EP1581638B1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 09/05/2007 | EP1463760B1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 09/05/2007 | EP1463733B1 Mitotic kinesin inhibitors |
| 09/05/2007 | EP1453535B1 Enveloped virus vaccine and method for production |
| 09/05/2007 | EP1283719B1 Apoptotic agents |
| 09/05/2007 | EP1267917B1 Angiogenic onchocerca volvulus proteins and uses thereof |
| 09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2007 | EP1113815B1 Immunogenic compositions and uses thereof |
| 09/05/2007 | EP1100829B1 Use of basiliximab in the treatment of rheumatoid arthritis or skin diseases |
| 09/05/2007 | EP1093465B1 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 09/05/2007 | EP0983342B1 Culture medium with soy bean extract as aminoacid source and no protein complexes of animal origin |
| 09/05/2007 | EP0690918B1 Protein tyrosine phosphatase ptp-s31 |
| 09/05/2007 | CN101031647A Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
| 09/05/2007 | CN101031587A Spore specific antibodies |
| 09/05/2007 | CN101031584A Domains and epitopes of meningococcal protein nmb1870 |
| 09/05/2007 | CN101031318A Cellular permissivity factor for viruses and uses thereof |
| 09/05/2007 | CN101028519A Pharmaceutical composition for treating immune diseases |
| 09/05/2007 | CN101028515A Anti-preisz bacterium and gingival carbon dioxide fibrophilic bacterium mixed IgY and its use in treating ozostomia and gingiva |
| 09/05/2007 | CN101028514A Method for producing vaccine for man by biological reactor |
| 09/05/2007 | CN101028513A Production and use for beach vibrio piscium efficient vaccine |
| 09/05/2007 | CN100335900C Novel self-assembly molecules |
| 09/05/2007 | CN100335637C Genetic immunization with nonstructural proteins of hepatitis c virus |
| 09/05/2007 | CN100335636C Thioredoxin gene of Schistosoma japonicum (Chinese Mainland Strain) and its cloning expression method and application |
| 09/05/2007 | CN100335628C Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-alphaza and its constructing method |
| 09/05/2007 | CN100335501C Antibody against human parathormone related peptides |
| 09/05/2007 | CN100335132C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors |
| 09/05/2007 | CN100335131C Recombinant herpesvirus of turkeys and use thereof |
| 09/05/2007 | CN100335130C Vaccines |
| 09/05/2007 | CN100335129C Mycobacterium triple nucleic acid vaccine for cattle |
| 09/05/2007 | CN100335121C Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN |
| 09/05/2007 | CN100335038C Preparation process and application of inorganic salt nanometer particle containing biological active material and enveloped Chinese medicinal ingredient |
| 09/04/2007 | US7265216 Cancer diagnosis; prevent gene expression in sample; induce immunology response |
| 09/04/2007 | US7265215 For use in diagnosis, prophylaxis |
| 09/04/2007 | US7265212 Anti-CD45RB antibodies |